The effect of ticlopidine was compared with flunarizine in patients with iliac–femoral and / or femoral–popliteal arteriosclerotic arteriopathy accompanied by lesions of the cervical arteries of no haemodynamic significance. In the lower limbs, plethysmography (strain gauge measurements) and Döppler ultrasonography integrated by spectral analysis of the cervical arteries showed qualitative and quantitative improvements of the regional haematic flow. Side-effects were negligible which suggests that ticlopidine is useful in the treatment of multiple arteriosclerotic arteriopathy.
Get full access to this article
View all access options for this article.
References
1.
AvelloneG., Mandala'V., NovoS.. Clinical experience with Ticlopidine on atherosclerotic vascular disease of the lower limbs. In: Abstract Book of the VIth International Congress on Thrombosis, Montecarlo, 23–25 October, 1980; p 37.
2.
BanI., ShionoyaY., NakataK.. A study on the effects of Ticlopidine for suppression of aggregation of platelets upon the factors of blood coagulation and fibrinolysis and on results of therapy with it for patients with peripheral vascular disease.Jpn J Clin Exp Med1978; 55: 2187–2193.
3.
KatsumuraT., MishimaY., KamyaK.: Therapeutic effect of Ticlopidine, a new inhibitor of platelet aggregation, on chronic arterial occlusive diseases. A double blind study with inactive placebo.Cardioangiology1980; 7: 396–406.
4.
LipsJ.P.M., SixmaJ.J., SchiphorstM.E.: The effect of Ticlopidine administration to humans on the binding of adenosine diphosphate to blood platelets.Thromb Res1980; 17: 19–27.
5.
De GaetanoG.: Piastrine, Trombosi e Aterosclerosi.Milan: Masson, 1982.
6.
FieschiC., PaolucciS., ButtinelliC.. Effetti di un trattamento cronico con ticlopidina su 24 pazienti con ischemia cerebrale reversibile. In: Recenti Acquisizioni in Tema di Terapia Antipiastrinica.Milan: Masson, 1983; pp 89–94.
7.
StieglerH., HessH., MietaschkA.. Einfluss von Ticlopidin auf die periphere obliterierende artheriopathie.Dtsch Med Wochenschr1984; 109: 1240–1243.
8.
AbeT., KazamaM., NaitoI.. Clinical evaluation of ticlopidine in the inhibition of platelet function. A multiclinic double-blind study in comparison with aspirin.Blood Vessels1980; 11: 142–151.
9.
CoccheriS., PalaretiG., PoggiM.. Alterazioni emoreologiche nelle vasculopatie cerebrali: il possibile ruolo della ticlopidina. In: Recenti Acquisizioni in Tema di Terapia Antipiastrinica.Milan: Masson, 1983; pp 83–87.
10.
WaycmanH., DavelooseD., SablayrollesM.. Spin label study of the effect of Ticlopidine on the erythrocyte membrane in normal and sickled cells.Blood1981; 58(suppl): 65A.
11.
LagardeM., GhaziI., DechavanM.: Effects of Ticlopidine on platelet Prostaglandine metabolism. Possible consequences for prostacycline production.Prostaglandins Med1979; 2: 433–439.
12.
PiovellaF., PiovellaL., AlmasioP.. The effect of Ticlopidine on culture human endothelial cells: possible influence on extracellular matrix formation.Thromb Haemost1981; 46: 404–409.
13.
LeeH., PatronR.C., RuanC.: The ‘in vitro’ effect of Ticlopidine on fibrinogen and factor VIII binding to human platelets.Thromb Haemost1981; 46: 67–70.
14.
O'BrienJ.R., EtheringtonM.D., ShuttleworthR.D.: Ticlopidine. A platelet drug. Effect in human volunteers.Thromb Res1978; 13: 245–254.
StaessenA.J.: Treatment of circulatory disturbance with Flunarizine and Cinnarizine. A multicentre, double blind and placebo-controlled evaluation.Vasa1977; 6: 59–71.
17.
Van NuetenJ.M., Van BeekJ., JanssenP.A.J.: Effect of Flunarizine on calcium-induced responses of peripheral vascular smooth muscle.Arch Int Pharmacodyn Ther1978; 232: 42–52.
18.
VerhaegenH., RoelsV., AdriaensenH.. The arteriolar effects of cinnarizine and flunarizine. Multitechnical investigations in normal volunteers and in patients with occlusive disease of the extremities secondary to arteriosclerosis.Angiology1974; 25: 261–278.
